Editor’s Pick: Wild Bioscience

T1Covered by 1 source · first reported by Nature / Science / Nature Biotechnology at 03 Nov, 00:00 UTC

Nature Biotechnology, Published online: 03 November 2026; doi:10.1038/s41587-026-03377-w Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Wild Bioscience is pursuing crop gene editing for higher yields and climate resilience.

Sources

• T1Editor’s Pick: Wild BioscienceNature / Science / Nature Biotechnology03 Nov, 00:00